AngioDynamics, Inc. (ANGO) vs Embecta Corp. (EMBC)
- AngioDynamics, Inc. ANGO 11.25 −2.85%
- Embecta Corp. EMBC 6.27 −2.79%
AngioDynamics, Inc. and Embecta Corp. are both Medical Instruments & Supplies companies. AngioDynamics, Inc. is the larger, with a market value of $487.0M against $365.5M — 1.3× the size. AngioDynamics, Inc. has negative trailing earnings, so its P/E is not meaningful; Embecta Corp. trades at 4.2×. AngioDynamics, Inc. grew revenue faster over the last twelve months: 8.20% against −7.60%. Embecta Corp. has the higher net margin (8.59% vs −10.1%) and the higher return on invested capital (21.4% vs −17.6%). Across the 18 metrics below, Embecta Corp. leads on 12 and AngioDynamics, Inc. on 6.
Valuation
Profitability
| Metric | ANGO | EMBC | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 55.65% | 59.03% | 54.29% |
| Operating margin | (11.24%) | 21.94% | 1.07% |
| Net margin | (10.12%) | 8.59% | (1.61%) |
| Free cash flow margin | 0.44% | 17.15% | 1.08% |
| Return on equity | (19.21%) | (13.65%) | (1.32%) |
| Return on assets | (12.98%) | 7.22% | 0.00% |
| Return on invested capital | (17.58%) | 21.44% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack